Clinical Trial to Determine the Effect of a Mouthwash on the Preservation of the Ecology of the Oral Microbiome and Its Compatibility With Health (BUCCOTHERM)
BUCCOTHERM : Randomized Clinical Trial to Determine the Effect of a Mouthwash on the Preservation of the Ecology of the Oral Microbiome and Its Compatibility With Health
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mevel Nicolas
- Phone Number: 02 99 28 25 55
- Email: dri@chu-rennes.fr
Study Contact Backup
- Name: Ganivet Anne
- Phone Number: 02 99 28 25 55
- Email: anne.ganivet@chu-rennes.fr
Study Locations
-
-
-
Rennes, France
- Chu Rennes
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older:
- with at least 20 permanent natural teeth, excluding crowns;
- affiliated to a social security system;
- having received information about the protocol and having given their free, informed and written consent.
Exclusion Criteria:
- with periodontitis in the month prior to inclusion;
- with significant carious lesions deeply modifying the oral microbiota in the month prior to inclusion;
- having undergone oral surgical treatment within 3 months prior to inclusion;
- wearing orthodontic appliances;
- having undergone periodontal procedures in the month prior to inclusion;
- suffering from severe chronic pathologies deemed incompatible with study entry;
- allergic to one of the swab components;
- allergic to any of the components of the BUCCOTHERM mouthwash or the placebo;
- on drugs that may cause gingival hypertrophy, such as Hydantoins (phenytoin), Dihydropyridines, Diltiazem or Ciclosporin;
- Medications that can cause gingival bleeding (anticoagulants, antiplatelet agents and aspirin);
- Antibiotic therapy or professional scaling in the month prior to inclusion;
- having used oral or topical antibiotics, antiseptics and/or antifungals (e.g., mouthwash, dental gels, etc.) in the month prior to inclusion.
- Subjects with poor written and spoken French language skills;
- previously included in the BUCCOTHERM study;
- simultaneously participating in another trial that may interfere with the conduct of the BUCCOTHERM study or in a period of exclusion after participation in another clinical study;
- protected persons (adults under legal protection (legal guardianship, curatorship, tutorship), persons deprived of liberty, pregnant or breastfeeding women, women of childbearing age without effective contraception (estrogen-progestin treatments, IUD, tubal ligation), minors.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: BuccoTherm
buccotherm mouthwash
|
twice a day for 14 weeks
|
|
Placebo Comparator: Placebo
placebo mouthwash
|
twice a day for 14 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Commensal species of the oral microbiota
Time Frame: week 14
|
Change from baseline in commensal species at 14 weeks
|
week 14
|
|
Alpha and beta diversity of the oral microbiota
Time Frame: week 14
|
Change from baseline in alpha and beta diversity at 14 weeks
|
week 14
|
|
Coefficient of dysbiosis/symbiosis of the oral microbiota
Time Frame: week 14
|
Change from baseline in coefficient of dysbiosis/symbiosis at 14 weeks
|
week 14
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Meuric Vincent, Rennes University Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 35RC21_9796_BUCCOTHERM
- 2021-A01541-40 (Other Identifier: N° IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.